Cardiothoracic & vascular anaesthesia

Analgesic efficacy of locoregional anesthesia techniques in cardiac surgery: a systematic review and network meta-analysis of randomized trials

Reg Anesth Pain MedPublished Systematic review and network meta-analysis of randomised trials

Authors' conclusion

IT demonstrated the largest reductions in opioid consumption and pain scores in the first 24 hours. ESPB and PIPB represent promising alternatives when neuraxial techniques are contraindicated, though effect sizes were smaller, often below thresholds of clinical relevance.

Study context

Population
Adults undergoing cardiac surgery
Participants
9,816 adults · 133 RCTs
Comparison
Locoregional analgesia techniques vs control
Outcome
Opioid consumption, pain scores, and time to first rescue analgesia
Follow-up
Within 24 hours postoperatively
Methodological detailsBayesian random-effects, GRADE certainty assessment
  • Bayesian random-effects
  • GRADE certainty assessment

Pooled result

As reported in the abstract

24-hour opioid consumption (MME) · 24 hours
CrI
Each group vs controlMD, MME (95% CrI)
IT
−14.8(−20.7 to −9.2)
ESPB
−9.7(−14.8 to −4.9)
Parasternal intercostal plane block (PIPB)
MD −6.3 MME (95% CrI 10.5 to −2.3)
Pain score on VAS at 24 hours, IT vs control (95% CrI −3.3; −0.7); IT produced the largest and consistent pain score reductions
−1.2 cm

Further pooled results

OutcomeMD (hours) (CrI)
ICU LOSESPB vs Control−8.3 (−13.7 to −2.8)
ICU LOSPIPB vs Control−7.2 (−12.2 to −2.3)
ICU LOSTEA vs Control−11.8 (−20.2 to −3.0)
OutcomeMD (days) (CrI)
Hospital LOSTEA vs Control · reduced by; only TEA reduced hospital LOS1.2 (−1.7 to −0.6)

Safety

No major block-related complications were reported

Original publication

Analgesic efficacy of locoregional anesthesia techniques in cardiac surgery: a systematic review and network meta-analysis of randomized trials. Reg Anesth Pain Med. Published 25 June 2026. doi:10.1136/rapm-2026-107773

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.